FOXO Technologies Inc. has outlined its forward-looking strategy focused on augmenting organic growth with acquisitions in the healthcare sector. The company has formed a wholly owned subsidiary, FOXO Acquisition Corporation (FAC), to serve as a vehicle for future acquisitions and has created a new series of preferred stock, Series E Cumulative Redeemable Secured Preferred Stock, to support these activities. FOXO plans to invest capital to expand the operations of its recent acquisition, Vector BioSource, Inc., targeting growth in the pharmaceutical services sector. The company is also actively seeking additional acquisition opportunities to further expand its portfolio of healthcare-related businesses.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FOXO Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-027961), on December 16, 2025, and is solely responsible for the information contained therein.